Stock EPIX ESSA PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

News ESSA Pharma Inc.

Equities

EPIX

CA29668H7085

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
6.3 USD +1.61% Intraday chart for ESSA Pharma Inc. +0.80% -4.55%
May. 20 Top Premarket Decliners MT
Mar. 06 Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Premarket Decliners
MT
ESSA Pharma: Fiscal Q2 Earnings Snapshot
AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
PR
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
AQ
Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
Norway's wealth fund pushes for more women on emerging market company boards
RE
ESSA Pharma : Passive Foreign Investment Company Statement
PU
ESSA Pharma: Fiscal Q1 Earnings Snapshot
AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
AQ
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PR
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
AQ
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
PR
ESSA Pharma: Fiscal Q4 Earnings Snapshot
AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023
AQ
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023
CI
Essa Pharma Insider Bought Shares Worth $133,274, According to a Recent SEC Filing
MT
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EPIX Stock
  4. News ESSA Pharma Inc.